Health Condition 1: L409- Psoriasis, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient diagnosed as psoriasis. 2. Age from 17 to 70 years. 3. Patient willing to participate in the research and voluntarily give written consent.
Exclusion criteria
Exclusion criteria: 1. Age less than 17 years and more than 70 years. 2. Pregnant and lactating mothers 3. Patient receiving panchakarma therapy or other conventional medicine.4. Psoriatic complications. 5. Patient of liver and kidney disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. CBC 2. ESR 3. TNF alpha, 4. CRP 5. Cytokines.Timepoint: At initial visit of patient and repeated after 3 months of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate the clinical effect of Khadir. 2. To evaluate the clinical effect of daruharidra. 3. To evaluate the clinical effect of nimb. 4 to evaluate the clinical effect of khadir, daruharidra and nimb in combination. 5. To evaluate the cell line study of khadir, daruharidra and nimb. Assessment scales are PASI score, IGA scale, Itching, Scaling, Erythema, Dryness, Roughness, Thickness.Timepoint: 3 months with 3 follow ups of one month each. | — |
Countries
India
Contacts
Institute of Medical Sciences